BIOL News Alert Biolase Technology (BIOL) 2.63 12/25/2014 05

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biolase Technology (BIOL) 2.63 $BIOL

Medical Laser Systems - 2014 Global Strategic Business Report
M2 - Thu Dec 18, 4:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/q7pvtt/medical_laser) has announced the addition of the "Medical Laser Systems - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Medical Laser Systems in US$ Million by the following Product Segments: - Surgical Lasers - Aesthetic Lasers - Ophthalmic Lasers - Diagnostic Lasers - Therapeutic Lasers - Accessories & Services The report profiles 119 companies including many key and niche players such as: - AngioDynamics, Inc. - Bausch & Lomb Incorporated - BIOLASE, Inc. - Biolitec AG - Cardiogenesis Corporation Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Issues 3. Medical Laser Systems: Product Overview 4. Product Introductions/Approvals 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 119 (including Divisions/Subsidiaries 145) - The United States (70) - Canada (3) - Japan (6) - Europe (53) - France (4) - Germany (22) - The United Kingdom (4) - Italy (7) - Spain (1) - Rest of Europe (15) - Asia-Pacific (Excluding Japan) (10) - Middle East (3) For more information visit http://www.researchandmarkets.com/research/q7...ical_laser
BIOL: 2.63 (-0.07)

Global Dental Devices, Dental Implants And Dental Diagnostic Devices Market Through 2020
M2 - Tue Dec 16, 8:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/tcpwzv/global_dental) has announced the addition of the "Global Dental Devices, Dental Implants And Dental Diagnostic Devices Market Through 2020" report to their offering. The global dental market comprises dental implants, dental prosthesis, dental biomaterials, dental crowns and bridges, dental imaging, dental units and equipment. In the past decade, the market has experienced a swelling expansion due to a surge in the uptake of implants, crowns and cosmetic dentistry. The key factors igniting the market growth include poor oral hygiene, a rise in incidences of oral diseases on the back of a growing elderly population, an improvement in oral care needs of individuals and an increasing disposable income in developing economies. The acceptance and proliferation of technology in terms of dental imaging (3D imaging), design and manufacturing (CAD/CAM) has resulted in better diagnosis, dental designs, patient compliance and a decrease in chair time. Globally, the US is the leading market for dental care devices with its Centers for Medicare and Medicaid Services (CMS) having estimated the demand for dental services in the country to approach $167 billion by 2015. As per The Association of Dental Dealers of Europe (ADEE), in 2011, the European dental market increased by 1.2% in terms of the total turnover for all countries with the number of active dentists increasing slightly by 0.8%. Another key market is the Asia-Pacific region. Japan is a relatively mature market in the APAC region, whereas in developing countries like India and China, rising disposable income of the middle class as well as growing dental-care awareness and consumer acceptance are contributing to market growth. Companies Mentioned - A-Dec Inc. - Biolase Inc. - Danaher Corporation - GC CORPORATION - Henry Schein Inc. - Midmark Corporation - NAKANISHI INC. - Nobel Biocare - Patterson Dental Supply Inc. - Planmeca Oy - Sirona Dental Systems Inc. - Straumann (SIX) - Sybron Dental Specialties Inc. - Young Innovations Inc. For more information visit http://www.researchandmarkets.com/research/tc...bal_dental
SIRO: 88.95 (+0.31), BIOL: 2.63 (-0.07), DHR: 86.79 (-0.27), HSIC: 137.87 (+0.15)

The Global Dental Device Market to hit $12.7 Billion by 2020 Propelled by a Surge in Oral Diseases and Poor Oral Hygiene: ABMRG
PR Newswire Europe - Tue Dec 09, 7:00AM CST
LONDON and NEW YORK, December 9, 2014 /PRNewswire/ --
SIRO: 88.95 (+0.31), BIOL: 2.63 (-0.07), PDCO: 48.79 (-0.02), SIX: 42.72 (+0.16), DHR: 86.79 (-0.27), HSIC: 137.87 (+0.15)

BIOLASE Launches New EPIC(TM) X diode laser in the United States; Now Dentists Can Delight Their Patients, Faster
PR Newswire - Mon Dec 01, 3:37PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in lasers, today introduced the EPIC(TM) X diode laser, the company's premier and most complete diode laser for the whole dental team.
BIOL: 2.63 (-0.07)

BIOLASE Introduces a New Commitment to Customer Care, Quality and Innovation at Greater New York Dental Meeting 2014
Business Wire - Fri Nov 28, 11:16AM CST
BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced a variety of advances and activities for the upcoming Greater New York Dental Meeting 2014 including the introduction of a new generation EPIC X diode laser, designed to be the premier and complete diode laser for the whole dental team. The Greater New York Dental Meeting, billed as the largest dental congress and exposition in the U.S., will be held from Friday, Nov. 28-Wednesday, Dec. 3, at the Jacob K. Javits Convention Center in New York City. The Exhibits at the meeting will be open from Sunday, Nov. 30-Wednesday Dec. 3.
BIOL: 2.63 (-0.07)

Biolase CMO bids adieu
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 3:12PM CST

BIOL: 2.63 (-0.07)

Biolase Announces Management Change
Business Wire - Wed Nov 19, 3:05PM CST
BIOLASE, Inc. (NASDAQ:BIOL), the world's leading manufacturer and distributor of dental lasers, today reported that Alexander K. Arrow, M.D. has resigned as Chief Medical Officer and will be leaving the Company effective December 3, 2014 to pursue other opportunities.
BIOL: 2.63 (-0.07)

InsiderInsights.com Daily Round Up 11/6/14: Chimerix, Biolase, Barrett Business Services, Ares Capital
InsiderInsights - at Seeking Alpha - Fri Nov 07, 1:06PM CST

D: 78.38 (+1.48), CBG: 34.93 (-0.06), PBFX: 18.81 (-0.14), LLY: 70.16 (+0.42), RL: 184.35 (+0.70), GOOG: 528.77 (-1.82), AER: 39.40 (+0.26), DO: 38.66 (-0.62), TPVG: 14.78 (+0.16), ARCC: 15.86 (+0.07), CMRX: 36.80 (+0.70), OPK: 9.63 (+0.21), BIOL: 2.63 (-0.07), WRI: 35.08 (-0.09), BBSI: 28.34 (+0.38), CUDA: 37.96 (+0.29), ACGL: 59.51 (-0.24), KPTI: 37.78 (+1.28)

InsiderInsights.com Daily Round Up 11/5/14: ELGX, NS, BIOL, NHF
InsiderInsights - at Seeking Alpha - Thu Nov 06, 3:19AM CST

VR: 41.51 (+0.19), JBHT: 84.91 (-0.02), FCX: 22.91 (+0.07), BBY: 38.89 (-0.80), NS: 57.17 (+0.24), LL: 63.91 (-0.41), ELGX: 15.35 (-0.06), ENFC: 14.42 (+0.01), RCL: 82.36 (+0.16), LMCA: 34.41 (+0.18), SPW: 86.64 (-0.11), OPK: 9.63 (+0.21), BIOL: 2.63 (-0.07), IMI: 1.98 (-0.02), NHF: 11.23 (+0.01), SIX: 42.72 (+0.16), TWTR: 37.61 (+0.04), SCHW: 30.67 (+0.01)

BIOLASE's (BIOL) CEO Jeff Nugent on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 10:01PM CST

BIOL: 2.63 (-0.07)

Biolase beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:26PM CST

BIOL: 2.63 (-0.07)

BIOLASE Reports 2014 Third Quarter Results
Business Wire - Tue Nov 04, 3:07PM CST
BIOLASE, Inc. (NASDAQ:BIOL), the world's leading manufacturer and distributor of dental lasers, today reported unaudited financial results for the third quarter and nine months ended September 30, 2014.
BIOL: 2.63 (-0.07)

BIOLASE to Raise $35 Million from Institutional and Individual Investors in Private Placement
Business Wire - Tue Nov 04, 12:00PM CST
BIOLASE, Inc. (NASDAQ:BIOL), the world's leading dental laser manufacturer and distributor, announced today that investors including Jack W. Schuler, Oracle Partners, L.P. and other Oracle funds, three funds managed by Camber Capital Management, LLC, Eagle Growth Partners I and II, Birchview Capital L.P., Trellus Partners, LP, CAC, LLC, and certain BIOLASE directors, officers, and employees have agreed to purchase $35 million of unregistered shares of the Company's common stock and warrants to purchase unregistered shares of the Company's common stock in a private placement transaction. Under the terms of the private placement, BIOLASE has agreed to sell an aggregate of 14,162,873 shares of its common stock at the price of $2.39 per share, the closing price quoted on NASDAQ on November 3, 2014. In addition, the investors will receive warrants to purchase up to an aggregate of 9,205,862 shares of BIOLASE(R) common stock at an exercise price of $4.00 per share. The warrants become exercisable six months after the closing of the private placement and have a term of three years from the date of issuance.
BIOL: 2.63 (-0.07)

Notable earnings after Tuesday's close
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:35PM CST

AMRS: 2.16 (-0.02), ITRI: 42.63 (+0.21), AWAY: 28.87 (+0.05), OKE: 50.71 (+0.33), HR: 27.54 (-0.02), NYMT: 7.71 (-0.06), OCLR: 1.87 (+0.02), ENPH: 14.38 (-0.02), ADEP: 8.35 (-0.16), CBSO: 27.51 (+0.58), NSTG: 13.93 (+0.02), MITT: 18.58 (-0.12), CRTO: 40.82 (unch), FOXA: 38.71 (-0.03), OKS: 41.05 (-0.04), JMBA: 14.53 (+0.14), IVR: 15.52 (-0.62), CSU: 25.08 (+0.10), MYGN: 36.50 (+0.28), JIVE: 6.08 (unch), GAS: 54.01 (+1.29), COUP: 17.44 (+0.69), NRP: 9.98 (+0.23), MOSY: 1.60 (+0.04), COHR: 62.43 (+0.22), DOX: 47.53 (+0.03), CKEC: 26.09 (+0.10), OAS: 16.66 (-1.05), PAYC: 26.49 (-0.88), PCYC: 121.84 (+1.15), AXLL: 41.52 (+0.11), NP: 59.82 (+0.19), BIRT: 6.60 (+0.02), ATVI: 20.35 (+0.12), EXAM: 41.16 (+0.96), P: 18.02 (-0.31), JAZZ: 165.33 (+1.83), PBPB: 12.11 (+0.08), EXEL: 1.29 (-0.01), CERS: 6.49 (+0.29), DVN: 60.21 (-1.26), FEYE: 32.38 (-1.11), CHUY: 19.28 (-0.19), FRGI: 56.97 (+0.47), GHDX: 32.44 (+1.32), PACD: 4.75 (-0.18), BIO: 120.32 (-0.04), BIOL: 2.63 (-0.07), JKHY: 63.50 (-0.07), KAR: 35.01 (-0.17), CDXS: 2.45 (-0.03), MPO: 1.63 (-0.05), FANG: 60.18 (-1.51), CORT: 2.94 (+0.06), CALD: 15.88 (+0.08)

Biolase reports November 4
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 9:12AM CDT

BIOL: 2.63 (-0.07)

BIOLASE(R) to Host Third Quarter Financial Results Conference Call on November 4, 2014
Business Wire - Thu Oct 23, 8:01AM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the world's leading dental laser manufacturer and distributor, announced today that the Company will host a conference call on Tuesday, November 4th, at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter and nine months ended September 30, 2014, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Time that same day.
BIOL: 2.63 (-0.07)

George Soros Picks KIOR, RSH, BIOL Soar On Monday
at The Street - Mon Sep 15, 3:43PM CDT
KiOR Inc (NASDAQ:KIOR), RadioShack Corporation (NYSE:RSH) and BIOLASE Inc (NASDAQ:BIOL) are today's top-gaining billionaire stock picks. On the losing end are NII Holdings Inc (NASDAQ:NIHD), dELiA...
ENZN: 1.02 (unch), DLIA: 0.01 (unch), BIOL: 2.63 (-0.07), RSH: 0.39 (+0.01)

Dental Equipment Market (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers) Current Trends, Opportunities - Global Forecast to 2019
M2 - Thu Sep 04, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h2kw9g/dental_equipment) has announced the addition of the "Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019" report to their offering. The global dental equipment market is expected to reach $7,138.9 million by 2019 from $5,416.3 million in 2014, growing at a CAGR of 5.7% from 2014 to 2019. Dental equipment systems are used for the diagnosis and treatment of oral diseases. These devices help detect abnormalities and diseases such as oral cancer. Factors such as the rising aging population, increasing demand for cosmetic dentistry, and dental tourism drive the growth of this market. Technological advancements, which help in the introduction of new and innovative devices in the market, are another major factor driving the growth of the market. The relatively untapped Asian markets have opened an array of opportunities for the market to grow. However, factors such as lack of reimbursements may restrain the growth of this market. On the basis of products, the dental equipment market is segmented into dental systems and equipment, dental lasers, and dental radiology equipment. The dental systems and equipment market is expected to grow at the highest CAGR. This growth can be attributed to the increasing need for dental services due to the rising aging population and dental tourism. Dental radiology equipment comprises the second largest segment in the market. This segment was further categorized into extraoral radiology, intraoral radiology, and hybrid units. The extraoral radiology segment is expected to grow at the highest CAGR in the dental radiology equipment market. The growth can be attributed to the increasing demand for the cone beam computed tomography (CBCT) systems. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium insights 5 Market Overview 6 Industry Trends 7 Dental Equipment Market 8 Global Dental Equipment Market, By Geography 9 Competitive Landscape 10 Company Profiles - 3M Company - A-Dec, Inc. - Biolase, Inc - Carestream Health, Inc. (A Subsidiary of Onex Corporation) - Danaher Corporation - Dentsply International, Inc. - Ivoclar Vivadent AG - Midmark Corporation - Planmeca OY - Sirona Dental Systems, Inc. For more information visit http://www.researchandmarkets.com/research/h2..._equipment
SIRO: 88.95 (+0.31), MMM: 166.96 (+0.09), BIOL: 2.63 (-0.07), DHR: 86.79 (-0.27)

BIOLASE Names Jeffrey M. Nugent Permanent President and Chief Executive Officer
Business Wire - Tue Sep 02, 8:01AM CDT
BIOLASE, Inc. (NASDAQ:BIOL), the world's leading manufacturer and distributor of dental lasers, today announced that Jeffrey M. Nugent has been named President and Chief Executive Officer by the Company's Board of Directors, effective immediately. Nugent has served as Acting Chief Executive Officer and a member of the Board of Directors since June 2014.
BIOL: 2.63 (-0.07), VRX.TO: 162.98 (-0.62)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading

Top 5 Most Recently Viewed Articles

Beta Glucan Market Set to Exceed USD 31 Billion by 2030

Updated Category News Views 56

Exploring the Growth of the Beta Glucan Market The beta glucan market is experiencing remarkable growth, largely driven by increasing awareness of its health benefits. More and more consumers are recognizing the importance of supporting their immune systems and managing cholesterol levels, which has led to a surge in demand across numerous sectors, including...

Continue Reading
AiPPT.com: Crafting the Next Era of AI-Driven Presentations

Updated Category News Views 177

Transforming Presentations with AiPPT.com In the evolving landscape of digital work, AiPPT.com stands out as a leading provider of AI-native tools that are reshaping the way presentations are crafted. As an advanced AI presentation maker, AiPPT.com is committed to enhancing user experiences by making the process of creating engaging and professional presentations much...

Continue Reading
Acme Mills Launches Natura: Revolutionizing Sustainable Fabrics

Updated Category News Views 244

Revolutionizing Textile Innovation with Natura Acme Mills Company, a recognized pioneer in textile manufacturing, has proudly unveiled its latest innovation, Natura. This new line of bio-based polylactic acid (PLA) fabrics aims to replace traditional petroleum-based materials such as PET, PP, and Nylon. With Natura, Acme Mills is not just promoting a product; it is...

Continue Reading
Class Action Alert for C3.ai, Inc. Investors - Join Now!

Updated Category News Views 123

Opportunity for C3.ai, Inc. Shareholders to Join Class Action Attention, shareholders of C3.ai, Inc. (NYSE: AI). A significant class action suit is currently underway, and your involvement could be crucial. If you purchased shares during the class period, there may be an opportunity for you to participate in a recovery process without the requirement of being a lead...

Continue Reading
EyePoint Pharmaceuticals: Innovations and Financial Insights

Updated Category News Views 224

EyePoint Pharmaceuticals Set to Showcase Q2 Financials EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pioneering company dedicated to developing advanced therapeutics for serious retinal diseases, plans to share its second quarter 2025 financial results. This announcement will be accompanied by a live conference call and webcast on a scheduled day, promising to provide...

Continue Reading